Pharma Pulse
search-icon

Tag: allopurinol

Urate Targets in Gout: Allopurinol and Febuxostat Strategies Explained

Urate Targets in Gout: Allopurinol and Febuxostat Strategies Explained

Posted On May 3, 2026 0

Learn how to manage gout effectively using treat-to-target strategies with allopurinol and febuxostat. Discover precise serum urate goals, dosing tips, and how to avoid common pitfalls in long-term treatment.

MOST POPULAR

Sleep Medications: Safety, Dependence, and Effective Alternatives

Sleep Medications: Safety, Dependence, and Effective Alternatives

Posted On December 1, 2025
Antidepressants: Types and Safety Profiles for Patients

Antidepressants: Types and Safety Profiles for Patients

Posted On December 18, 2025
Doxylamine for Athletes: Sleep Benefits, Performance Gains & Potential Risks

Doxylamine for Athletes: Sleep Benefits, Performance Gains & Potential Risks

Posted On September 22, 2025
Bacterial vs. Viral Infections: Key Differences and Treatments

Bacterial vs. Viral Infections: Key Differences and Treatments

Posted On February 8, 2026
HBV Reactivation: How Biologics and Chemotherapy Trigger Liver Danger - And How to Prevent It

HBV Reactivation: How Biologics and Chemotherapy Trigger Liver Danger - And How to Prevent It

Posted On January 12, 2026

Categories

  • Health (214)
  • Health Economics (18)

ARCHIVES

  • September 2026 (2)
  • August 2026 (12)
  • July 2026 (15)
  • June 2026 (12)
  • May 2026 (13)
  • April 2026 (7)
  • March 2026 (11)
  • February 2026 (11)
  • January 2026 (26)
  • December 2025 (29)
  • November 2025 (18)
  • October 2025 (30)
Pharma Pulse

Menu

  • About Pharma Pulse Weekly
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact Us

Recent Posts

Sleep Medications: Safety, Dependence, and Effective Alternatives

Sleep Medications: Safety, Dependence, and Effective Alternatives

Posted On December 1, 2025
Antidepressants: Types and Safety Profiles for Patients

Antidepressants: Types and Safety Profiles for Patients

Posted On December 18, 2025
© 2026. All rights reserved.